Table 1: Summary of all 20 specimens of 9 NLPHL patients.
|
Case |
Date |
Specimen |
Histopathology |
FCI |
CD57+ (%) |
CD4+CD8+ (%) |
|
1-A 1-B |
03/08 05/08 |
Core Excision |
Atypical NLPHL |
Positive Positive |
27 30 |
33 14 |
|
2-A 2-B |
06/03 05/08 |
Excision Excision |
NLPHL RH |
Positive Negative |
48 7 |
21 1 |
|
3-A 3-B |
01/10 02/10 |
Core Excision |
Atypical NLPHL |
Positive Positive |
40 47 |
10 3 |
|
4-A 4-B |
05/10 06/10 |
Core Core |
NLPHL NLPHL |
Positive Positive |
25 25 |
20 21 |
|
5-A 5-B |
06/08 12/11 |
Excision Excision |
NLPHL RH |
Positive Negative |
19 4 |
12 2 |
|
6-A 6-B |
02/07 11/12 |
Excision Excision |
NLPHL NLPHL |
Positive Positive |
24 13 |
21 9 |
|
7-A 7-B |
04/12 06/12 |
Excision Core |
NLPHL Atypical |
Positive Positive |
15 13 |
19 6 |
|
8-A 8-B 8-C |
06/07 10/07 01/11 |
Excision Excision Excision |
RH/PTGC RH/PTGC NLPHL |
Positive Positive Positive |
13 15 19 |
27 23 22 |
|
9-A 9-B 9-C |
03/03 04/08 09/09 |
Excision Excision Excision |
NLPHL RH RH/PTGC |
Positive Positive Positive |
22 6 9 |
1 6 8 |
FCI: Flow Cytometric Immunophenotyping; NLPHL: Nodular
Lymphocyte-Predominant Hodgkin Lymphoma; RH: Reactive Hyperplasia, RH/PTGC: Reactive Hyperplasia with
Progressive Transformation of Germinal Centers.